Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Prospective, Interventional, Cohort, Superiority Study to Evaluate the Benefit of Rapid COVID-19 Genomic Sequencing (the COVID-19 GENOMICS UK Project) on Infection Control in Preventing the Spread of the Virus in United Kingdom NHS Hospitals

NCT04405934 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04405934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Prospective, Interventional, Cohort, Superiority Study to Evaluate the Benefit of Rapid COVID-19 Genomic Sequencing (the COVID-19 GENOMICS UK Project) on Infection Control in Preventing the Spread of the Virus in United Kingdom NHS Hospitals
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2020
Completion date
October 8, 2021
Enrollment
2,170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, coronavirus infection, covid-19, nosocomial infection, sars-cov 2